Fluorescence-Based Perfusion Assessment During Complex Reconstruction

Abstract

Fluorescence-based perfusion assessment has emerged as a transformative adjunct in complex reconstructive surgery, offering real-time, objective evaluation of tissue vascularity. The integration of this technology into intraoperative workflows has demonstrated significant potential to optimize surgical outcomes, reduce flap failure rates, and guide clinical decision-making. This review synthesizes current evidence, elucidates the mechanisms underpinning fluorescence imaging, and provides clinicians with a comprehensive overview of clinical applications, limitations, and future directions for fluorescence-guided perfusion assessment during complex reconstruction.

Introduction

Complex reconstructive procedures, encompassing microsurgical free flaps, composite tissue transplantation, and local flap reconstructions, demand precise intraoperative evaluation of tissue perfusion. Traditional assessment methods, such as clinical observation, capillary refill, and Doppler ultrasound, are often subjective and may fail to detect subtle perfusion deficits. Fluorescence-based imaging, particularly with indocyanine green (ICG), has gained traction as an objective, reproducible tool to assess microvascular integrity and perfusion adequacy. This article provides a detailed review of fluorescence-based perfusion assessment, its clinical implications, and evidence supporting its use in complex reconstructive surgery.

Epidemiology / Disease Burden

The global burden of reconstructive surgery has grown alongside the rising incidence of trauma, oncologic resections, and congenital anomalies requiring soft tissue coverage. Flap failure and wound breakdown remain significant complications, reported in up to 5–15% of free flap procedures and contributing to prolonged hospitalization, increased costs, and morbidity. The need for reliable intraoperative perfusion assessment is underscored by the prevalence of these complications, particularly in high-risk populations such as diabetics, smokers, and patients with peripheral vascular disease.

Pathophysiology

Successful reconstruction hinges on the establishment and maintenance of adequate tissue perfusion. Microvascular compromise, whether arterial or venous, can lead to ischemia, necrosis, and flap loss. The pathophysiology involves interruption of arterial inflow, venous outflow obstruction, or vasospasm, resulting in insufficient oxygen delivery and metabolic waste accumulation. Early identification of compromised perfusion is critical, as timely intervention can salvage at-risk tissues and improve outcomes.

Risk Factors

Several patient- and procedure-related factors predispose to impaired perfusion in reconstructive surgery. Comorbidities such as diabetes mellitus, peripheral arterial disease, smoking, and previous radiation therapy compromise microvascular health. Technical factors, including vessel size mismatch, tension at the anastomosis, and prolonged ischemia during flap transfer, further increase the risk. Recognizing these risk factors enables targeted monitoring and intraoperative decision-making to minimize complications.

Clinical Features

Inadequate tissue perfusion intraoperatively may manifest as pallor, delayed capillary refill, decreased temperature, and diminished bleeding from cut surfaces. However, these signs are subjective and can be influenced by anesthetic factors or ambient temperature. Postoperatively, compromised perfusion presents as progressive duskiness, venous congestion, or tissue breakdown. Early detection of these features is vital for flap salvage, underscoring the need for objective assessment tools.

Diagnosis

Fluorescence-based perfusion assessment employs near-infrared fluorescence imaging following intravenous administration of indocyanine green. The dye, bound to plasma proteins, rapidly circulates and emits fluorescence when illuminated with near-infrared light. Specialized cameras capture dynamic perfusion patterns, enabling real-time visualization of arterial inflow and venous drainage. Quantitative analysis of fluorescence intensity and time-to-peak values provides objective data on tissue viability, surpassing the limitations of conventional assessment.

Treatment & Management

Intraoperative fluorescence imaging informs critical decisions regarding flap design, zone of perfusion, and anastomosis selection. Areas demonstrating delayed or poor fluorescence may be revised or excluded from the final reconstruction to reduce the risk of necrosis. Postoperatively, fluorescence-guided assessment aids in the early detection of perfusion compromise and prompt intervention, such as surgical exploration or vascular revision. Integration of fluorescence imaging into reconstructive workflows has been associated with reduced re-exploration rates and improved flap survival.

Recent Advances / Emerging Therapies

Recent advancements include quantitative software algorithms that provide objective perfusion maps and threshold values for clinical decision-making. Novel fluorophores with longer emission wavelengths and enhanced tissue penetration are under investigation. Integration of artificial intelligence and machine learning holds promise for automated analysis and prediction of perfusion-related complications. These innovations are expanding the scope and reliability of fluorescence-based assessment in complex reconstruction.

Guideline Recommendations

While consensus guidelines are evolving, several professional societies advocate for the use of fluorescence imaging as an adjunct to clinical judgment in high-risk reconstructive procedures. The American Society of Plastic Surgeons and European guidelines emphasize its role in reducing flap failure rates and optimizing surgical outcomes. However, they caution that fluorescence assessment should complement not replace clinical expertise, and advocate for further research to refine protocols and standardize interpretation.

Conclusion

Fluorescence-based perfusion assessment represents a paradigm shift in complex reconstructive surgery, offering objective, real-time evaluation of tissue vascularity. Its integration into intraoperative decision-making enhances surgical precision, reduces complications, and improves patient outcomes. Ongoing research and technological innovation are poised to further refine its application, establish standardized protocols, and expand its clinical utility. Surgeons should remain abreast of advances in fluorescence imaging to harness its full potential in optimizing reconstructive success.